These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7357547)

  • 21. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.
    Hyafil F; Vergely C; Du Vignaud P; Grand-Perret T
    Cancer Res; 1993 Oct; 53(19):4595-602. PubMed ID: 8402633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of 1- -D-arabinofuranosylcytosine-induced cell lethality.
    Karon M; Benedict WF; Rucker N
    Cancer Res; 1972 Dec; 32(12):2612-5. PubMed ID: 4674677
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of testosterone on growth of P388 leukemia cell line in vivo and in vitro. Distribution of peripheral blood T lymphocytes and cell cycle progression.
    Aboudkhil S; Henry L; Zaid A; Bureau JP
    Neoplasma; 2004; 51(5):368-74. PubMed ID: 15640941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
    Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential antitumor agent: steroidal bilactam ester of p-N, N-bis (2-chloroethyl) aminophenylacetic acid.
    Catsoulacos P; Camoutsis C; Papageorgiou A
    Anticancer Res; 1995; 15(3):827-30. PubMed ID: 7645966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
    J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro malignant transformation of cells derid from mouse prostate in the presence of 3-methylcholanthrene.
    Chen TT; Heidelberger C
    J Natl Cancer Inst; 1969 Jun; 42(6):915-25. PubMed ID: 5793191
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunomodulation in established murine tumors: response and survival rate enhancement by blood leukocyte-augmenting substance 236 (Cl-), a novel synthetic compound.
    Pérez Cuadrado S; Moreno Koch Mdel C; Fernández Pérez C; Castejón Castán LM; Pérez Villalobos C; González Mateos MJ; Olmos CL
    Clin Cancer Res; 2003 Nov; 9(15):5776-85. PubMed ID: 14654563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid aza-steroid alkylators in the treatment of colon cancer.
    Trafalis DT
    Cancer Lett; 2006 Nov; 243(2):202-10. PubMed ID: 16412564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combined effect of antibiotics and surface-active agents on gram-negative bacteria].
    Pis'ko GT; Gudz' OV; Borisova EV; Pis'ko TG
    Vrach Delo; 1980 Mar; (3):118-20. PubMed ID: 6990623
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily.
    Nitta K; Ozaki K; Ishikawa M; Furusawa S; Hosono M; Kawauchi H; Sasaki K; Takayanagi Y; Tsuiki S; Hakomori S
    Cancer Res; 1994 Feb; 54(4):920-7. PubMed ID: 8313382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors intervening in the variability of the antitumoral activity of thymus extracts].
    Potop I; Holban-Petrescu R; Ghinea E; Mreană G; Juvină E
    Stud Cercet Endocrinol; 1972; 23(1):29-32. PubMed ID: 5063193
    [No Abstract]   [Full Text] [Related]  

  • 35. The hollow fiber assay: continued characterization with novel approaches.
    Hall LA; Krauthauser CM; Wexler RS; Hollingshead MG; Slee AM; Kerr JS
    Anticancer Res; 2000; 20(2A):903-11. PubMed ID: 10810375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mode of action of ionic surface-active compounds in bacteria. 3. Light and electron microscopy studies on the effect of dimethylaminoacetic-acid-dodecylamide chlorbenzylate (DADCl) on mycobacteria].
    Wahn K; Zapf K
    Zentralbl Bakteriol Orig A; 1972 Feb; 219(2):227-48. PubMed ID: 4146138
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigation of soft long chain quaternary ammonium compounds as co-factors to enhance in vitro gene delivery.
    Másson M; Benediktsson T; Thorsteinsson T; Loftsson T
    Pharmazie; 2006 Jun; 61(6):564-6. PubMed ID: 16826980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mode of action of ionic surface-active compounds in bacteria. I. Bacteriological and physiological studies on mycobacteria].
    Wahn K; Zapf K
    Zentralbl Bakteriol Orig; 1969; 211(4):514-29. PubMed ID: 4989452
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor activity and toxicity of cisplatin analogs.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Treat Rep; 1982 Jan; 66(1):135-46. PubMed ID: 7198010
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
    Aklilu F; Park M; Goltzman D; Rabbani SA
    Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.